Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

15,800

Employees15,800

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

15,800

Employees15,800

EW Key Statistics

Market cap

45.06B

Market cap45.06B

Price-Earnings ratio

51.46

Price-Earnings ratio51.46

Dividend yield

—

Dividend yield—

Average volume

4.12M

Average volume4.12M

High today

$77.43

High today$77.43

Low today

$76.50

Low today$76.50

Open price

$77.20

Open price$77.20

Volume

1.68M

Volume1.68M

52 Week high

$95.25

52 Week high$95.25

52 Week low

$58.93

52 Week low$58.93

EW News

TipRanks 11h

Edwards Lifesciences’ PASCAL System Trial: A Potential Game-Changer for Tricuspid Valve Repair

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium...

Simply Wall St 3d

Edwards Lifesciences Removed From Multiple Russell Growth Indexes

experienced a 7.91% price increase over the last quarter, amidst significant developments. On June 30, 2025, the company was removed from several Russell indice...

Analyst ratings

50%

of 32 ratings

Buy

50%

Hold

43.8%

Sell

6.3%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.